Evidence map›Paper›PMID 27994059›Full record

ArticleThe Journal of biological chemistry2017

Assessing Oxidative Stress in Tumors by Measuring the Rate of Hyperpolarized [1-13C]Dehydroascorbic Acid Reduction Using 13C Magnetic Resonance Spectroscopy.

Kerstin N Timm, De-En Hu, Michael Williams, Alan J Wright, Mikko I Kettunen, Brett W C Kennedy, Timothy J Larkin, Piotr Dzien, Irene Marco-Rius, Sarah E Bohndiek and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Quo Vadis HyperpolarizedZeitschrift fur medizinische Physik · 2025
    Review
  4. Review
  5. Article
  6. Imaging Techniques in Pharmacological Precision Medicine.Handbook of experimental pharmacology · 2023
    Article
  7. Latest Advances in Imaging Oxidative Stress in Cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Review
  8. Article
  9. Review
  10. Review
  11. Imaging Brain Metabolism Using HyperpolarizedTrends in neurosciences · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. HyperpolarizedNeoplasia (New York, N.Y.) · 2019
    Review
  18. Review
  19. Theranostics and metabolotheranostics for precision medicine in oncology.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kerstin N TimmFrom the Department of Biochemistry, University of Cambridge, Cambridge CB2 0RE, United Kingdom; the Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
De-En HuFrom the Department of Biochemistry, University of Cambridge, Cambridge CB2 0RE, United Kingdom; the Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Michael Williamsthe Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Alan J Wrightthe Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Mikko I KettunenFrom the Department of Biochemistry, University of Cambridge, Cambridge CB2 0RE, United Kingdom; the Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Brett W C KennedyFrom the Department of Biochemistry, University of Cambridge, Cambridge CB2 0RE, United Kingdom; the Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Timothy J LarkinFrom the Department of Biochemistry, University of Cambridge, Cambridge CB2 0RE, United Kingdom; the Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Piotr DzienFrom the Department of Biochemistry, University of Cambridge, Cambridge CB2 0RE, United Kingdom; the Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Irene Marco-RiusFrom the Department of Biochemistry, University of Cambridge, Cambridge CB2 0RE, United Kingdom; the Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Sarah E Bohndiekthe Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom; the Department of Physics, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Kevin M BrindleFrom the Department of Biochemistry, University of Cambridge, Cambridge CB2 0RE, United Kingdom; the Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom. Electronic address: kmb1001@cam.ac.uk.
University of Cambridge · GBCancer Research UK · GB

Funding

Cancer Research UK 16465Cancer Research UK 17242
6 · The paper itself

Abstract

Rapid cancer cell proliferation promotes the production of reducing equivalents, which counteract the effects of relatively high levels of reactive oxygen species. Reactive oxygen species levels increase in response to chemotherapy and cell death, whereas an increase in antioxidant capacity can confer resistance to chemotherapy and is associated with an aggressive tumor phenotype. The pentose phosphate pathway is a major site of NADPH production in the cell, which is used to maintain the main intracellular antioxidant, glutathione, in its reduced state. Previous studies have shown that the rate of hyperpolarized [1-

Indexed as

Oxidative StressAnimalsCarbon IsotopesCell Line, TumorDehydroascorbic AcidHumansIsotope LabelingMagnetic Resonance SpectroscopyMiceNADPNeoplasmsCarbon IsotopesDehydroascorbic AcidNADP13Cdehydroascorbic acidglutathioneglutathione peroxidasehyperpolarizationin vivo imagingoxidative stresspentose phosphate pathway (PPP)tumor metabolism

Identifiers

PMID27994059
PMCPMC5290948
OpenAlexW2566219312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.